|

A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy

RECRUITINGPhase 4Sponsored by Clinical Hospital Centre Zagreb
Actively Recruiting
PhasePhase 4
SponsorClinical Hospital Centre Zagreb
Started2025-01-01
Est. completion2027-11-30
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted

Summary

The goal of this prospective, randomized, controlled study is to compare remimazolam besilat/sufentanyl and propofol/sufentanyl in patients during colonoscopic polypectomies procedures. Patients undergoing colonoscopic polypectomies in procedural sedation using remimazolam besylate/sufentanyl are circulatory and respiratory as or more stable when compared with propofol/sufentanyl sedation.

Eligibility

Age: 18 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients both male and female
* ages 18 to 60 years,
* with one or more colonic polyps confirmed by colonoscopy and scheduled for a colonoscopy and polypectomy
* The duration of the colonoscopy ranges from 30 to 50 minutes.
* ASA status (American Society of Anaesthesiologists physical status) I-III.
* BMI (Body mass index) 18.5-29.9 kg/m2.
* Only patients who signed an informed consent waiver and consented to participate in the research study.

Exclusion Criteria:

* Patients aged \>60 years
* ASA status IV-V,
* BMI \>29.9 kg/m2,
* a high risk of vomiting, regurgitation and/or aspiration of gastric contents.
* Patients with:
* uncontrolled hypertension (systolic pressure \>160 mmHg),
* heart disease (cardiomyopathy, cardiac-rhythm disorder, left ventricular ejection fraction \<45%, stenosis or heart valve insufficiency and coronary heart disease)
* lung disease (pneumonia, chronic obstructive pulmonary disease, asthma and pulmonary tumors),
* kidney diseases (kidney failure, GF 30/59 ml/min/1.73m2),
* liver diseases,
* coagulation disorders
* lymphatic tissue diseases
* extended malignant disease.
* History of allergy on nutritional allergens including soy bean, benzodiazepines, propofol or opioids.
* Patients who currently use analgesic medications or other psycho-pharmaceuticals.
* History of illicit drug use.
* Children, pregnant and nursing women.
* Alcohol dependency.
* Patients involved in other clinical research studies,
* patients who refused to take part in the research or have not signed the written informed consent form.

Conditions3

Colonic PolypDepressionSedation Complication

Interventions2

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.